These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 13623976)

  • 21. Persistence of antibodies after vaccination with living attenuated poliovirus.
    PLOTKIN SA; JERVIS G; NORTON T; STOKES J; KOPROWSKI H
    J Am Med Assoc; 1959 May; 170(1):8-12. PubMed ID: 13640974
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of previous vaccination with killed vaccine on the susceptibility of the alimentary tract to infection with poliomyelitis virus.
    WILTERDINK JB; VERLINDE JD
    Arch Gesamte Virusforsch; 1963; 12():441-54. PubMed ID: 14001111
    [No Abstract]   [Full Text] [Related]  

  • 23. The detection of poliovirus and other enteric viruses in flies. Results of tests carried out during an oral poliovirus vaccine trial.
    RIORDAN JT; PAUL JR; YOSHIOKA I; HORSTMANN DM
    Am J Hyg; 1961 Sep; 74():123-36. PubMed ID: 14492407
    [No Abstract]   [Full Text] [Related]  

  • 24. [The present status of poliomyelitis inoculation with live avirulent polio virus. Report from an information tour].
    BUSER F
    Schweiz Med Wochenschr; 1960 Jan; 90():44-7. PubMed ID: 13806390
    [No Abstract]   [Full Text] [Related]  

  • 25. [THE PERSISTENCE OF POLIOMYELITIS VIRUS TYPE 1 IN VACCINATED INDIVIDUALS AND IN THEIR ENVIRONMENT].
    BILEK M; KOEENIG I; LUTYNSKI R
    Przegl Epidemiol; 1965; 19():97-100. PubMed ID: 14317139
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide].
    PITZURRA M; CUSMA N; BISCATTI O; DONATI M
    Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination-induced poliomyelitis in Idaho; preliminary report of experience with Salk poliomyelitis vaccine.
    PETERSON LJ; BENSON WW; GRAEBER FO
    J Am Med Assoc; 1955 Sep; 159(4):241-4. PubMed ID: 13251869
    [No Abstract]   [Full Text] [Related]  

  • 29. [Viral excretion after mass vaccination with attenuated polio virus in Hungary].
    DOEMOEK J; MOLNAR E; JANCSO A
    Offentl Gesundheitsdienst; 1961 Oct; 23():504-6. PubMed ID: 13886900
    [No Abstract]   [Full Text] [Related]  

  • 30. A survey of poliovirus neutralizing antibody in Newfoundland, 1959-60.
    OZERE RL; ROZEE KR
    Can Med Assoc J; 1961 Jul; 85(2):63-7. PubMed ID: 13731845
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oral poliovirus vaccination. Retrospect and perspectives].
    JOPPICH G
    Med Welt; 1962 Dec; 50():2647-50. PubMed ID: 13964869
    [No Abstract]   [Full Text] [Related]  

  • 32. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of antibodies neutralizing the 3 types of poliovirus in children of the second and third stages of childhood given antipoliomyelitis vaccination with the Salk type of vaccine].
    SEGAGNI E; ANSALDI N; NIGRO N
    Minerva Pediatr; 1960 Apr; 12():518-22. PubMed ID: 14444520
    [No Abstract]   [Full Text] [Related]  

  • 34. Response of pregnant women and their infants to poliomyelitis vaccine; distribution of poliovirus antibody in pregnant women before and after vaccination; transfer, persistence, and induction of antibodies in infants.
    DA SILVA MM; PREM KA; JOHNSON EA; MCKELVEY JL; SYVERTON JT
    J Am Med Assoc; 1958 Sep; 168(1):1-5. PubMed ID: 13575112
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of 0.1 ml whole blood samples for testing neutralizing antibodies against poliovirus.
    LUND E
    Arch Gesamte Virusforsch; 1958; 8(1):131-8. PubMed ID: 13534321
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of attenuated poliovirus in an epidemic area, Managua, Nicaragua, 1958.
    MARTINS DA SILVA M; LOPEZ BERRIOS M; ALCOCER JJ
    Am J Hyg; 1960 Mar; 71():179-92. PubMed ID: 13856129
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of vaccination with formalin inactivated vaccine upon gastrointestinal infection with polioviruses.
    LEPOW ML; ROBBINS FC; WOODS WA
    Am J Public Health Nations Health; 1960 Apr; 50(4):531-42. PubMed ID: 14415906
    [No Abstract]   [Full Text] [Related]  

  • 38. [VIROLOGICAL STUDIES OF PUBLIC BATH WATERS FOLLOWING ORAL POLIOMYELITIS VACCINATION].
    WITT G
    Arch Hyg Bakteriol; 1964 Apr; 148():188-93. PubMed ID: 14345532
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees.
    BODIAN D; NATHANSON N
    Bull Johns Hopkins Hosp; 1960 Sep; 107():143-62. PubMed ID: 13801930
    [No Abstract]   [Full Text] [Related]  

  • 40. A simple method for concentration of live and formaldehyde-inactivated poliovirus.
    GROSSOWICZ N; MERCADO A; GOLDBLUM N
    Proc Soc Exp Biol Med; 1960 Apr; 103():872-4. PubMed ID: 13829716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.